Immune system and immunodeficiency

Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Ferri GM, Martinez CB, Acevedo J, …, Szalat RE, Sloan JM

Breast Cancer Research and Treatment215(1)DOI: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitorsPubMed: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Abdallah M, Arters F, Patel J, …, Szalat R

Blood Advances8(23):5935-5938DOI: Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosisPubMed: Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

Malphettes M, Gérard L, Galicier L, …, Szalat R, …, Oksenhendler E

Clinical Infectious Diseases61(2):e13-e19DOI: Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune ComplicationsPubMed: Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile

Szalat R, Monsel G, Le Goff W, …, Asli B

Journal of the American Academy of Dermatology73(5):809-820DOI: The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profilePubMed: The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile

Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy

Szalat R, Pirault J, Fermand J‐, …, Goff WL

Journal of Internal Medicine276(3):269-284DOI: Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathyPubMed: Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy

Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature

Szalat R, Ghillani-Dalbin P, Jallouli M, Amoura Z, Musset L, Cacoub P, Sène D

Autoimmunity Reviews9(10):652-656DOI: Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literaturePubMed: Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature

Single-cell transcriptomics of AL amyloidosis reveals pathogenic mechanisms, immune interactions and altered clonal and polyclonal plasma cell phenotypes

Smith J, Samur M, Talluri S, …, Szalat R

Blood146(Supplement 1):3923-3923DOI: Single-cell transcriptomics of AL amyloidosis reveals pathogenic mechanisms, immune interactions and altered clonal and polyclonal plasma cell phenotypes

Bone marrow plasma cells and immune microenvironment transcriptomic architecture in AL amyloidosis during daratumumab based therapy

Szalat R, Talluri S, Wong S, Morgan G, Sanchorawala V, Munshi N, et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS31:S176-S176

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Abdallah M, Arters F, Patel J, …, Szalat RE

Blood142(Supplement 1):7432-7432DOI: When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Favorable Progression-Free Survival Associated with Immune Bio-Markers Modulated By Pomalidomide in Relapsed/Refractory Multiple Myeloma: An Analysis of Phase III Study

Prabhala R, Samur MK, Talluri S, …, Szalat R, …, Munshi NC

Blood134(Supplement_1):1784-1784DOI: Favorable Progression-Free Survival Associated with Immune Bio-Markers Modulated By Pomalidomide in Relapsed/Refractory Multiple Myeloma: An Analysis of Phase III Study

PF588 SIGNIFICANT POM EFFECT ON THE IMMUNE‐CELL PROFILES IN B, T AND NK SUBSETS IN A LARGE COHORT CLINICAL TRIAL IN RELAPSED/REFRACTORY MYELOMA

Prabhala R, Samur M, Talluri S, …, Szalat R, …, Munshi N

HemaSphere3(S1):246DOI: PF588 SIGNIFICANT POM EFFECT ON THE IMMUNE‐CELL PROFILES IN B, T AND NK SUBSETS IN A LARGE COHORT CLINICAL TRIAL IN RELAPSED/REFRACTORY MYELOMA

Perturbation in B Cell-Subsets Can Explain the Observed Suppression of Uninvolved Immunoglobulins and Their Impact on T Tell-Subsets As Well As Patients Outcome in Myeloma

Prabhala R, Acharya S, Stekla M, Talluri S, Szalat R, Nanjappa P, et al.

Blood130:3049

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Talbot A, Gérard L, Szalat R, …, Arnulf B

Blood122(21):5348-5348DOI: Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Dermatoses neutrophiliques et gammapathies monoclonales : 26 cas et revue de la littérature

Monsel G, Szalat R, Battistella M, Vignon-Pennamen MD, Bagot M, Fermand JP, Asli B, Rybojad M

Annales de Dermatologie et de Vénéréologie140(12):S605DOI: Dermatoses neutrophiliques et gammapathies monoclonales : 26 cas et revue de la littérature